Literature DB >> 9788262

Immunolocalization of aromatase in human minor salivary glands of the lower lip with primary Sjögren's syndrome.

K Onodera1, H Sasano, R Ichinohasama, K Ooya.   

Abstract

The enzyme aromatase is involved in the conversion of androgens to estrogens and in the modulation of various androgenic and estrogenic actions. Abnormalities of estrogen metabolism have been postulated to play roles in the development and/or pathophysiology of Sjögren's syndrome. In the present study, aromatase was immunolocalized in 75 cases of inflammatory disorders of human minor salivary glands of the lower lip. These included cases of primary Sjögren's syndrome (19 cases), of chronic sialadenitis (34 cases) and of mucous extravasation cysts (22 cases), in order to clarify the possible involvement of in situ estrogen production in primary Sjögren's syndrome. Aromatase immunoreactivity was detected in myoepithelial cells of acini and in interstitial cells adjacent to acini and ducts in 13/19 (68%) cases of primary Sjögren's syndrome. In contrast, aromatase expression was detected in only six of 34 (18%) cases of chronic sialadenitis and in seven of 22 (32%) cases of mucous extravasation cyst. These results suggest that increased aromatase expression in minor salivary glands with primary Sjögren's syndrome in premenopausal women may be involved in the biological features of primary Sjögren's syndrome through the production of estrogens in situ and possibly through the aggravation of the inflammatory reaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788262     DOI: 10.1111/j.1440-1827.1998.tb03838.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  [Sex hormones and dry eye].

Authors:  F Schirra; B Seitz; N Knop; E Knop
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

2.  Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjögren's syndrome.

Authors:  Michelle Spaan; Pauliina Porola; Mikael Laine; Blaz Rozman; Masayuki Azuma; Yrjö T Konttinen
Journal:  J Cell Mol Med       Date:  2009-02-27       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.